United Kingdom
Having originally trained as a chemist, I have over 25 years’ experience within the Pharmaceutical industry, working mainly in process development as a synthetic chemist. Roles within GSK included lab chemist, chemistry project leader for projects spanning early through to late clinical phases, team manager, Chemistry Manufacturing and Control (CMC) project manager and coordination of CMC related due diligence activities. I am a GSK mutagenic impurity risk assessment subject matter expert and co-chair the Impurities Oversight Panel. As a Senior Fellow at GSK, I work across industry within trade associations around aspects of ICH M7 and presents externally on best practice for mutagenic impurity control strategies for pharmaceutical products.
